ArriVent BioPharma, Inc. (NASDAQ: AVBP)

$30.90 -0.08 (-0.27%)
As of Apr 22, 2026 11:12 AM
Sector: Healthcare Industry: Biotechnology CIK: 0001868279
P/E -6.87
Add ratio to table...

About

ArriVent BioPharma, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for oncology, with a particular emphasis on non-small cell lung cancer (NSCLC). The company operates within the highly competitive biotechnology sector, leveraging its expertise in targeted therapies to address unmet medical needs in cancer treatment. ArriVent BioPharma's strategic approach involves both internal research and development efforts and external collaborations to advance its pipeline of therapeutic candidates. The...

Read more

Statement of Income Location, Balance Breakdown of Revenue (2025)

Peer comparison

Companies in the Biotechnology
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 VRTX Vertex Pharmaceuticals Inc / Ma 111.34 Bn 28.15 9.28 -
2 REGN Regeneron Pharmaceuticals, Inc. 78.06 Bn 17.30 5.44 1.99 Bn
3 ALNY Alnylam Pharmaceuticals, Inc. 41.92 Bn 152.39 13.31 -
4 RVMD Revolution Medicines, Inc. 28.36 Bn -25.11 34,170.56 -
5 ZLAB Zai Lab Ltd 25.77 Bn -147.06 106.30 0.20 Bn
6 MESO Mesoblast Ltd 24.32 Bn -190.54 1,414.27 0.12 Bn
7 MRNA Moderna, Inc. 21.25 Bn -7.52 10.93 0.59 Bn
8 RPRX Royalty Pharma plc 20.83 Bn 27.08 8.76 8.95 Bn